Skip to main content
Journal ArticleOPEN ACCESS

Significance of age in acute myeloid leukemia patients younger than 30 years

  • Creutzig U
  • Büchner T
  • Sauerland M
  • et al.
Cancer (2008) 112(3) 562-571
DOI: 10.1002/cncr.23220
N/ACitations
Citations of this article
25Readers
Mendeley users who have this article in their library.

This article is free to access.

Abstract

Abstract 10.1002/cncr.23220.abs BACKGROUND. Data on the impact of age in acute myeloid leukemia (AML) patients <30 years treated in pediatric and adult trials are scarce. METHODS.

Cite

CITATION STYLE

APA

Creutzig, U., Büchner, T., Sauerland, M. C., Zimmermann, M., Reinhardt, D., Döhner, H., & Schlenk, R. F. (2008). Significance of age in acute myeloid leukemia patients younger than 30 years. Cancer, 112(3), 562–571. https://doi.org/10.1002/cncr.23220

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free